Celgene to Acquire Delinia, Inc.
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 7/14/2026
- Wall Street ends lower as Iran tensions dampen risk appetite; chipmakers drop
- SK Hynix’s record plunge drags down global chip stocks
- Oil up 9% to one-month high as US says it will blockade entire Iranian coastline, all vessels
- Ditching streaming could boost Disney stock by 40%, Wells Fargo says
- AstraZeneca stock dips as HSBC downgrades stock on 'tough path ahead'
Celgene (CELG) PT Raised to $148 at Oppenheimer
January 26, 2017 3:32 PM ESTOppenheimer analyst Leah Rush Cann raised her price target on Celgene (NASDAQ: CELG) to $148.00 (from $141.00) while maintaining a Outperform rating.
Rush Cann commented, "Celgene reported a strong quarter and year-end that was in line with expectations. The outlook for Celgenes clinical... More
